{"frequencyBands":{"HP:0040280":[100,100],"HP:0040281":[80,99],"HP:0040282":[30,79],"HP:0040283":[5,29],"HP:0040284":[1,4],"HP:0040285":[0,0]},"page":{"anchorSlug":"constitutional-megaloblastic-anemia-with-severe-neurologic-disease","columns":[{"gene":"","key":"population-ff3b750dc0286b5890b9","label":"Megaloblastic anemia due to dihydrofolate reductase deficiency","mondoId":"MONDO:0013456","onsetQualifier":null,"originColumnKey":"MONDO:0013456/OMIM:613839","originalViews":[{"key":"MONDO:0013456/OMIM:613839","label":"Megaloblastic anemia due to dihydrofolate reductase deficiency","scopeLabel":"OMIM:613839","sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"recordKeys":["07686cad2b6966e618f51be2a6a8212e4af9b20e4fc9819f5d625c8214c6fda7","0d8cc4596a9d5319862da5cdb6df419dfae19805f550f2f1f4b7423c4429c556","2cf05f47433d89eb035bc5072e376dbde1c604f417ab9445d74f72ac241ffc03","3d38860e375363564a4e7518bd11d28454898d2e9fdcf73df89dd6707955c4ce","3e444fac8b5576d9dfc06e84be0a1b79b6ba3aa5b96aca5c4e36047be112fdb2","45c29ca04db720ba3a9333ecbb9d6966abbf7f0dcb2626037552efd4b36baac6","50ceaa0161c816afaaedf651619a6f53f52423e9b8f4ee0512779503a33767bb","51e281346d7118914a1a5c4f437f023dad321686a607b205a70d448dbdeb9e06","5a7ddf5c32a5d65ca05146058c0166654a0da9cc06ca0e3f073de5bed9356571","63479a4482d5382f1855c0a70a9c23acb3c95c8061414a5ffcc3ee7e042eb125","6821d0262780995e7b7a63e036ac085e502406490d5b53aa200608953b38f315","6b4c3953e35848b0bfa463382171e336096e09c2374da14d98e5d4a18f9d3d29","6f58b137e77bfca6ee4326a2d49e3498142556569ad2f955a947f6968ce1282c","7127b46ac4e99a4415544486cca1daa4ace850977880173c4e50f0556dac3835","7dafd2640b1e7c84d0318dc858c5fa265cc27f4de9d5ba18891869cc6b4f641a","92d0b2390f9bddb8e316624f85bb17b48c4cef18e490eeb615bf75f472183d16","982ca9d97e9cf36831218f107007cb83019955acf82e3fde794b1c88f6708a94","9bdebaa4d20a52cc290d50099d9735b5768811220af756ec90cb6d1b476be2ef","b05289121b7b885fa15e70e37508e25382a9f5d5c707b26105e518ba03dc0415","b477c120206cc16618949dfa61b292cad0bd0f9eebb045d84c374a225d34d8a3","c9e6eef26a1498488d83de70612c578150b9911fd2171beee281114170f53289","d4a5f3c9b4f64d8bded19dcdd5781a60eb752f1cc5309dbabe19f98748044590","fe5315db139a83c5612937a6d4a1ea6a9dd2dd338adadfdab28f0ed823f40936"],"recordQualifiers":{},"scopeLabel":"OMIM:613839","sourceIds":["OMIM:613839"],"sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"comparison":{"collapseColumnsLabel":"Show default populations","defaultColumnKeys":["population-ff3b750dc0286b5890b9"],"expandColumnsLabel":"Show all source populations","intro":"Features recorded for this MONDO node. Related-node evidence is available through separately scoped comparisons.","primaryFeatureIds":["HP:0040087","HP:0011149","HP:0001251","HP:0001321","HP:0002059","HP:0012446","HP:0012448"],"scopeNoteHtml":"<p>Each column retains its native condition identifier, assessed population and annotation references. Counts are not pooled.</p>"},"coverage":{"countRecords":6,"emptyColumnKeys":[],"hpoRelease":"2026-06-23","narrativeSourceChanges":[],"records":23,"sourceGroups":{"omim":17,"published":6}},"features":[{"hpoId":"HP:0040087","label":"Abnormal circulating folate concentration","primary":true},{"hpoId":"HP:0011149","label":"Absence seizure with eyelid myoclonia","primary":true},{"hpoId":"HP:0001251","label":"Ataxia","primary":true},{"hpoId":"HP:0001321","label":"Cerebellar hypoplasia","primary":true},{"hpoId":"HP:0002059","label":"Cerebral atrophy","primary":true},{"hpoId":"HP:0012446","label":"Decreased CSF 5-methyltetrahydrofolate concentration","primary":true},{"hpoId":"HP:0012448","label":"Delayed myelination","primary":true},{"hpoId":"HP:0025097","label":"Eyelid myoclonus","primary":false},{"hpoId":"HP:0011968","label":"Feeding difficulties","primary":false},{"hpoId":"HP:0001290","label":"Generalized hypotonia","primary":false},{"hpoId":"HP:0002121","label":"Generalized non-motor (absence) seizure","primary":false},{"hpoId":"HP:0001263","label":"Global developmental delay","primary":false},{"hpoId":"HP:0002240","label":"Hepatomegaly","primary":false},{"hpoId":"HP:0001252","label":"Hypotonia","primary":false},{"hpoId":"HP:0025435","label":"Increased circulating lactate dehydrogenase concentration","primary":false},{"hpoId":"HP:0005518","label":"Increased mean corpuscular volume","primary":false},{"hpoId":"HP:0000952","label":"Jaundice","primary":false},{"hpoId":"HP:0001889","label":"Megaloblastic anemia","primary":false},{"hpoId":"HP:0000980","label":"Pallor","primary":false},{"hpoId":"HP:0001876","label":"Pancytopenia","primary":false},{"hpoId":"HP:0002421","label":"Poor head control","primary":false},{"hpoId":"HP:0005484","label":"Secondary microcephaly","primary":false},{"hpoId":"HP:0001873","label":"Thrombocytopenia","primary":false}],"ledeHtml":"Constitutional megaloblastic anemia with severe neurologic disease is an autosomal recessive metabolic disorder characterized by the hematologic findings of megaloblastic anemia and variable neurologic symptoms. These symptoms range from severe developmental delay and generalized seizures in infancy to childhood absence epilepsy with learning difficulties to lack of symptoms. This disease is caused by mutations in the DHFR gene.","mondoId":"MONDO:0013456","node":{"canonicalSlug":"constitutional-megaloblastic-anemia-with-severe-neurologic-disease","comparisons":[{"documentSha256":"b28cc58df768ab1500dbaffe311db6ddf96bc92911a01c5e3e5ca197d89b0759","key":"legacy-constitutional-megaloblastic-anemia-with-severe-neurologic-disease","kind":"legacy","label":"constitutional megaloblastic anemia with severe neurologic disease","memberIds":["MONDO:0013456"],"mondoId":"MONDO:0013456","url":"https://kcjyutqgtpgteszueluf.supabase.co/storage/v1/object/public/community-guides/learn-data/constitutional-megaloblastic-anemia-with-severe-neurologic-disease.b28cc58df768ab1500dbaffe311db6ddf96bc92911a01c5e3e5ca197d89b0759.json"}],"contexts":[],"lifecycle":"active","narrative":{"causes":[],"contentForm":"summary","independentCorroborationEstablished":false,"matchMethod":"automatic-identity-and-attribution","name":"Constitutional megaloblastic anemia with severe neurologic disease","originalSourceId":"ORPHA:319651","paragraphs":["Constitutional megaloblastic anemia with severe neurologic disease is an autosomal recessive metabolic disorder characterized by the hematologic findings of megaloblastic anemia and variable neurologic symptoms. These symptoms range from severe developmental delay and generalized seizures in infancy to childhood absence epilepsy with learning difficulties to lack of symptoms. This disease is caused by mutations in the DHFR gene."],"rawAttribution":"ORPHA:319651","reviewed":null,"scope":"exact","source":"GARD","sourceRelease":"2026-10-21T16:59:26Z","upstream":"OMIM:613839","url":"https://rarediseases.info.nih.gov/diseases/11000"},"ownColumnKeys":["population-ff3b750dc0286b5890b9"],"publication":"published","relationships":[{"kind":"parent","label":"megaloblastic anemia","mondoId":"MONDO:0001700","slug":null},{"kind":"parent","label":"hereditary anemia","mondoId":"MONDO:0016624","slug":null},{"kind":"parent","label":"disorder of folate metabolism and transport","mondoId":"MONDO:0017313","slug":null}],"schemaVersion":1,"searchIndex":"/node-search/manifest.json","sourceHolds":{},"summaryHolds":[],"translation":"pending"},"records":[{"frequencyKind":"count","key":"07686cad2b6966e618f51be2a6a8212e4af9b20e4fc9819f5d625c8214c6fda7","raw":{"aspect":"P","body_system":"blood","disease_id":"OMIM:613839","disease_name":"Megaloblastic anemia due to dihydrofolate reductase deficiency","evidence":"PCS","frequency_raw":"2/3","hpo_id":"HP:0001889","is_excluded":false,"label":"Megaloblastic anemia","onset_id":null,"reference":"PMID:21310277","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"0d8cc4596a9d5319862da5cdb6df419dfae19805f550f2f1f4b7423c4429c556","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:613839","disease_name":"Megaloblastic anemia due to dihydrofolate reductase deficiency","evidence":"PCS","frequency_raw":"1/3","hpo_id":"HP:0025435","is_excluded":false,"label":"Increased circulating lactate dehydrogenase concentration","onset_id":null,"reference":"PMID:21310277","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"reported","key":"2cf05f47433d89eb035bc5072e376dbde1c604f417ab9445d74f72ac241ffc03","raw":{"aspect":"P","body_system":"digestive","disease_id":"OMIM:613839","disease_name":"Megaloblastic anemia due to dihydrofolate reductase deficiency","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0002240","is_excluded":false,"label":"Hepatomegaly","onset_id":null,"reference":"OMIM:613839","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"3d38860e375363564a4e7518bd11d28454898d2e9fdcf73df89dd6707955c4ce","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:613839","disease_name":"Megaloblastic anemia due to dihydrofolate reductase deficiency","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0002059","is_excluded":false,"label":"Cerebral atrophy","onset_id":null,"reference":"OMIM:613839","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"3e444fac8b5576d9dfc06e84be0a1b79b6ba3aa5b96aca5c4e36047be112fdb2","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:613839","disease_name":"Megaloblastic anemia due to dihydrofolate reductase deficiency","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0002121","is_excluded":false,"label":"Generalized non-motor (absence) seizure","onset_id":null,"reference":"OMIM:613839","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"45c29ca04db720ba3a9333ecbb9d6966abbf7f0dcb2626037552efd4b36baac6","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"OMIM:613839","disease_name":"Megaloblastic anemia due to dihydrofolate reductase deficiency","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0002421","is_excluded":false,"label":"Poor head control","onset_id":null,"reference":"OMIM:613839","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"50ceaa0161c816afaaedf651619a6f53f52423e9b8f4ee0512779503a33767bb","raw":{"aspect":"P","body_system":"digestive","disease_id":"OMIM:613839","disease_name":"Megaloblastic anemia due to dihydrofolate reductase deficiency","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0011968","is_excluded":false,"label":"Feeding difficulties","onset_id":null,"reference":"OMIM:613839","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"51e281346d7118914a1a5c4f437f023dad321686a607b205a70d448dbdeb9e06","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:613839","disease_name":"Megaloblastic anemia due to dihydrofolate reductase deficiency","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0012448","is_excluded":false,"label":"Delayed myelination","onset_id":null,"reference":"OMIM:613839","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"5a7ddf5c32a5d65ca05146058c0166654a0da9cc06ca0e3f073de5bed9356571","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:613839","disease_name":"Megaloblastic anemia due to dihydrofolate reductase deficiency","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0001263","is_excluded":false,"label":"Global developmental delay","onset_id":null,"reference":"OMIM:613839","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"63479a4482d5382f1855c0a70a9c23acb3c95c8061414a5ffcc3ee7e042eb125","raw":{"aspect":"P","body_system":"blood","disease_id":"OMIM:613839","disease_name":"Megaloblastic anemia due to dihydrofolate reductase deficiency","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0001876","is_excluded":false,"label":"Pancytopenia","onset_id":null,"reference":"OMIM:613839","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"6821d0262780995e7b7a63e036ac085e502406490d5b53aa200608953b38f315","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:613839","disease_name":"Megaloblastic anemia due to dihydrofolate reductase deficiency","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0025097","is_excluded":false,"label":"Eyelid myoclonus","onset_id":null,"reference":"OMIM:613839","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"count","key":"6b4c3953e35848b0bfa463382171e336096e09c2374da14d98e5d4a18f9d3d29","raw":{"aspect":"P","body_system":"blood","disease_id":"OMIM:613839","disease_name":"Megaloblastic anemia due to dihydrofolate reductase deficiency","evidence":"PCS","frequency_raw":"3/3","hpo_id":"HP:0005518","is_excluded":false,"label":"Increased mean corpuscular volume","onset_id":null,"reference":"PMID:21310277","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"reported","key":"6f58b137e77bfca6ee4326a2d49e3498142556569ad2f955a947f6968ce1282c","raw":{"aspect":"P","body_system":"digestive","disease_id":"OMIM:613839","disease_name":"Megaloblastic anemia due to dihydrofolate reductase deficiency","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0000952","is_excluded":false,"label":"Jaundice","onset_id":null,"reference":"OMIM:613839","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"count","key":"7127b46ac4e99a4415544486cca1daa4ace850977880173c4e50f0556dac3835","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:613839","disease_name":"Megaloblastic anemia due to dihydrofolate reductase deficiency","evidence":"PCS","frequency_raw":"2/3","hpo_id":"HP:0011149","is_excluded":false,"label":"Absence seizure with eyelid myoclonia","onset_id":null,"reference":"PMID:21310277","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"reported","key":"7dafd2640b1e7c84d0318dc858c5fa265cc27f4de9d5ba18891869cc6b4f641a","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"OMIM:613839","disease_name":"Megaloblastic anemia due to dihydrofolate reductase deficiency","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0001290","is_excluded":false,"label":"Generalized hypotonia","onset_id":null,"reference":"OMIM:613839","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"92d0b2390f9bddb8e316624f85bb17b48c4cef18e490eeb615bf75f472183d16","raw":{"aspect":"P","body_system":"skin","disease_id":"OMIM:613839","disease_name":"Megaloblastic anemia due to dihydrofolate reductase deficiency","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0000980","is_excluded":false,"label":"Pallor","onset_id":null,"reference":"OMIM:613839","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"982ca9d97e9cf36831218f107007cb83019955acf82e3fde794b1c88f6708a94","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"OMIM:613839","disease_name":"Megaloblastic anemia due to dihydrofolate reductase deficiency","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0001252","is_excluded":false,"label":"Hypotonia","onset_id":null,"reference":"OMIM:613839","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"9bdebaa4d20a52cc290d50099d9735b5768811220af756ec90cb6d1b476be2ef","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:613839","disease_name":"Megaloblastic anemia due to dihydrofolate reductase deficiency","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0005484","is_excluded":false,"label":"Secondary microcephaly","onset_id":null,"reference":"OMIM:613839","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"count","key":"b05289121b7b885fa15e70e37508e25382a9f5d5c707b26105e518ba03dc0415","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:613839","disease_name":"Megaloblastic anemia due to dihydrofolate reductase deficiency","evidence":"PCS","frequency_raw":"0/3","hpo_id":"HP:0040087","is_excluded":true,"label":"Abnormal circulating folate concentration","onset_id":null,"reference":"PMID:21310277","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"reported","key":"b477c120206cc16618949dfa61b292cad0bd0f9eebb045d84c374a225d34d8a3","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:613839","disease_name":"Megaloblastic anemia due to dihydrofolate reductase deficiency","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0001321","is_excluded":false,"label":"Cerebellar hypoplasia","onset_id":null,"reference":"OMIM:613839","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"c9e6eef26a1498488d83de70612c578150b9911fd2171beee281114170f53289","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:613839","disease_name":"Megaloblastic anemia due to dihydrofolate reductase deficiency","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0001251","is_excluded":false,"label":"Ataxia","onset_id":null,"reference":"OMIM:613839","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"count","key":"d4a5f3c9b4f64d8bded19dcdd5781a60eb752f1cc5309dbabe19f98748044590","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:613839","disease_name":"Megaloblastic anemia due to dihydrofolate reductase deficiency","evidence":"PCS","frequency_raw":"2/2","hpo_id":"HP:0012446","is_excluded":false,"label":"Decreased CSF 5-methyltetrahydrofolate concentration","onset_id":null,"reference":"PMID:21310277","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"reported","key":"fe5315db139a83c5612937a6d4a1ea6a9dd2dd338adadfdab28f0ed823f40936","raw":{"aspect":"P","body_system":"blood","disease_id":"OMIM:613839","disease_name":"Megaloblastic anemia due to dihydrofolate reductase deficiency","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0001873","is_excluded":false,"label":"Thrombocytopenia","onset_id":null,"reference":"OMIM:613839","source_release":"2026-06-23"},"sourceGroups":["omim"]}],"referenceLabels":{},"references":{"causeHtml":"<p class=\"section-source\">Source: <a href=\"https://rarediseases.info.nih.gov/diseases/11000\" rel=\"noreferrer\">GARD</a></p><details class=\"deep-dive\"><summary>Narrative source and scope</summary><dl><dt>Content</dt><dd>summary</dd><dt>Scope</dt><dd>exact</dd><dt>Match method</dt><dd>automatic-identity-and-attribution</dd><dt>Upstream attribution</dt><dd>OMIM:613839</dd></dl></details>","identityNote":"MONDO identifies this node. Native source populations, annotation references and qualified comparison views retain their original scopes.","importantHtml":""},"sections":[{"bodyHtml":"<p>Constitutional megaloblastic anemia with severe neurologic disease is an autosomal recessive metabolic disorder characterized by the hematologic findings of megaloblastic anemia and variable neurologic symptoms. These symptoms range from severe developmental delay and generalized seizures in infancy to childhood absence epilepsy with learning difficulties to lack of symptoms. This disease is caused by mutations in the DHFR gene.</p><p class=\"section-source\">Source: <a href=\"https://rarediseases.info.nih.gov/diseases/11000\" rel=\"noreferrer\">GARD</a></p>","key":"overview","title":"Overview"}],"sharedSources":[],"slug":"constitutional-megaloblastic-anemia-with-severe-neurologic-disease","sourceDocuments":[{"name":"GARD: Constitutional megaloblastic anemia with severe neurologic disease","reviewed":null,"source_release":"2026-10-21T16:59:26Z","url":"https://rarediseases.info.nih.gov/diseases/11000"}],"sourceNote":"","synonyms":["DHFR deficiency","dihydrofolate reductase deficiency","megaloblastic anaemia due to dihydrofolate reductase deficiency"],"takeawayHtml":"","title":"constitutional megaloblastic anemia with severe neurologic disease"},"schemaVersion":1}
